期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 12, 期 10, 页码 7163-7185出版社
MDPI
DOI: 10.3390/ijms12107163
关键词
ROS; mitochondria; peroxiredoxin III; cancer; antioxidant; oxidative stress; therapy
资金
- Ministry of Health, Welfare and Family affairs, Republic of Korea [0920040]
- National Research Foundation of Korea (NRF)
- Ministry of Education, Science and Technology [2010-0020224]
Mitochondria are involved either directly or indirectly in oncogenesis and the alteration of metabolism in cancer cells. Cancer cells contain large numbers of abnormal mitochondria and produce large amounts of reactive oxygen species (ROS). Oxidative stress is caused by an imbalance between the production of ROS and the antioxidant capacity of the cell. Several cancer therapies, such as chemotherapeutic drugs and radiation, disrupt mitochondrial homeostasis and release cytochrome c, leading to apoptosome formation, which activates the intrinsic pathway. This is modulated by the extent of mitochondrial oxidative stress. The peroxiredoxin (Prx) system is a cellular defense system against oxidative stress, and mitochondria in cancer cells are known to contain high levels of Prx III. Here, we review accumulating evidence suggesting that mitochondrial oxidative stress is involved in cancer, and discuss the role of the mitochondrial Prx III antioxidant system as a potential target for cancer therapy. We hope that this review will provide the basis for new strategic approaches in the development of effective cancer treatments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据